Healthequity (HQY) Cash & Current Investments (2013 - 2026)

Healthequity's Cash & Current Investments history runs 14 years deep, the most recent figure standing at $265.4 million for Q2 2026.

• In Q2 2026, Cash & Current Investments fell 7.82% year-over-year to $265.4 million; the TTM figure through Apr 2026 stood at $265.4 million (down 7.82% YoY), while the FY2026 annual figure was $318.9 million, up 7.76% from the prior year.
• Cash & Current Investments for Q2 2026 stood at $265.4 million, down from $318.9 million in the prior quarter.
• The five-year high for Cash & Current Investments was $404.0 million in Q1 2024, with the low at $161.2 million in Q2 2022.
• The 5-year median for Cash & Current Investments is $289.1 million (2023), against an average of $275.8 million.
• The sharpest annual moves came in 2022 and 2023: Cash & Current Investments plunged 78.11% in 2022, then jumped 64.14% in 2023.
• Healthequity's Cash & Current Investments stood at $210.2 million in 2022, then soared by 58.93% to $334.1 million in 2023, then fell by 3.56% to $322.2 million in 2024, then dropped by 4.01% to $309.3 million in 2025, then dropped by 14.19% to $265.4 million in 2026.
• Business Quant data shows HQY's Cash & Current Investments at $265.4 million in Q2 2026, $318.9 million in Q1 2026, and $309.3 million in Q4 2025.